New Techniques to Reduce Intra-operative Bleeding During Complex Liver Resection

This observational study introduced an new advanced bleeding control strategy during complex liver resection.This newly described "stepwise vascular control" technique was efficacious and feasible to control intra-operative bleeding in complex hepatectomy involving second hepatic hilum and retro-hepatic inferior vena cava.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Surgical Blood Loss Blood Loss, Surgical Hemorrhage Intraoperative Complications Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

41 year–68 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

tumor size is more than 5cm in diameter;
these tumor were close to or were compressing main hepatic veins and RIVC directly;
Pugh-Child Grade is A or Indocyanine green retention rate at 15min (ICG15%) is less than 10% .

Treatment and study plan

stepwise vascular control

Procedure

Before liver parenchymal resection, we performed "total hepatic vascular preparation for occlusion" with portal triad (PT), infra-hepatic inferior vena cava (IIVC), and supra-hepatic inferior vena cava (SIVC) preparation in order. Then we performed step-by-step vascular occlusion according to the individual bleeding situation.

Primary outcomes

blood loss during liver resection

Time frame: duration of operation time

Sponsors and collaborators

Lead sponsor

Tongji Hospital

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2016
First posted: Dec 19, 2016
Registry last updated: Dec 19, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed